Four Thought Financial Partners, LLC Pfizer Inc Transaction History

Four Thought Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $17,760 - $20,394	-686 Reduced 2.08%	32,238 $895 Million
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $3,814 - $4,955	146 Added 0.45%	32,924 $948 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $87,894 - $102,739	2,739 Added 9.12%	32,778 $1.09 Billion
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $63,173 - $73,090	-1,749 Reduced 5.5%	30,039 $1.1 Billion
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $49,513 - $64,458	1,257 Added 4.12%	31,788 $1.3 Billion
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $1.27 Million - $1.66 Million	30,531 New	30,531 $1.56 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Four Thought Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial Partners, LLC with notifications on news.